Company Analysis

Elevance Health, Inc. (ELV)

NYSE: ELV · Hospital & Medical Service Plans · Indianapolis, IN · filing with the SEC since 2001
Grade6.5
◀ Past 6.7● Present 7.4▶ Future 5.0

Filings

287 filings since 2017 beside 403 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026
Due nextLarge accelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends. by Mar 1, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 21 days after the quarter ended. The proxy statement was last filed Mar 27, 2026.

Filings a yearinsider forms included
6573646063696165
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 3 times in the last 36 months, the newest Feb 26, 2026.
Insider forms 403

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 10, 2026 8-K item 7.01 Investor disclosure (Regulation FD) · Current report
Oct 28, 2026 S-3ASR Shelf registration
Oct 21, 2026 10-Q Quarterly report Sep 30, 2026
Oct 21, 2026 8-K items 2.02, 9.01 Results released · Current report
Sep 10, 2026 8-K item 7.01 Investor disclosure (Regulation FD) · Current report
Jul 15, 2026 10-Q Quarterly report Jun 30, 2026
Jul 15, 2026 8-K items 2.02, 9.01 Results released · Current report
Jun 17, 2026 11-K Employee plan annual report Dec 31, 2025
Jun 17, 2026 11-K Employee plan annual report Dec 31, 2025
Jun 10, 2026 8-K item 7.01 Investor disclosure (Regulation FD) · Current report
May 13, 2026 8-K item 5.07 Shareholder vote · Current report
Apr 29, 2026 SCHEDULE 13G Large holder notice
Apr 22, 2026 10-Q Quarterly report Mar 31, 2026
Apr 22, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 7, 2026 PX14A6G Shareholder proxy notice
Mar 27, 2026 DEFA14A Extra proxy material
Mar 27, 2026 DEF 14A Proxy statement May 13, 2026
Mar 26, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 10, 2026 8-K item 7.01 Investor disclosure (Regulation FD) · Current report
Mar 2, 2026 8-K item 8.01 Other event · Current report
Feb 26, 2026 8-K items 5.02, 7.01 Officer or director change; Investor disclosure (Regulation FD) · Current report
Feb 6, 2026 10-K Annual report Dec 31, 2025
Jan 28, 2026 8-K items 2.02, 9.01 Results released · Current report
Dec 10, 2025 8-K item 5.02 Officer or director change · Current report
Nov 10, 2025 8-K item 7.01 Investor disclosure (Regulation FD) · Current report
Oct 21, 2025 8-K items 2.02, 9.01 Results released · Current report
Oct 21, 2025 10-Q Quarterly report Sep 30, 2025
Sep 15, 2025 8-K items 8.01, 9.01 Other event · Current report Sep 8, 2025
Sep 9, 2025 424B3 Shelf offering
Sep 8, 2025 FWP Offering communication
Sep 8, 2025 424B3 Shelf offering
Sep 4, 2025 8-K item 7.01 Investor disclosure (Regulation FD) · Current report
Jul 28, 2025 8-K items 5.02, 9.01 Officer or director change · Current report
Jul 17, 2025 10-Q Quarterly report Jun 30, 2025
Jul 17, 2025 8-K items 2.02, 9.01 Results released · Current report
Jun 24, 2025 11-K Employee plan annual report Dec 31, 2024
Jun 24, 2025 11-K Employee plan annual report Dec 31, 2024
May 28, 2025 8-K item 7.01 Investor disclosure (Regulation FD) · Current report
May 14, 2025 8-K item 5.07 Shareholder vote · Current report
May 7, 2025 SCHEDULE 13G/A Large holder update, amended
40 of 287 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton ELV · research, not advice